Session 3: A Detailed Review of US and EEC Documentation Requirements for the Final Dosage Form and Available Guidelines

1989 ◽  
Vol 23 (3) ◽  
pp. 427-427
Author(s):  
Anthony C. Cartwright
2020 ◽  
Vol 11 (11) ◽  
pp. 21-24
Author(s):  
Nutan Kumari ◽  
Ankita Tripathi ◽  
Sapna Chaudhar ◽  
Bhawna Mehta ◽  
Khushboo Bhardawaj

Nanoparticles are an emerging field of modern science. It is solid colloidal particles. They consist of micro molecular materials in which the active ingredients is dissolved, entrapped or encapsulated or adsorbed or attached. The size of nanoparticles ranges from 1 to 100 nm. It can be synthesized chemically or biologically. Nanoparticles are used in various purposes like in drug delivery, in food, in medicine, in cosmetics etc. There are lots of advantages of nanomedicine over other dosage form. Nanoparticles show high solubility as well as higher bioavailability on site of action. This review focuses on synthesis, biosynthesis, types, application, advantage, disadvantage, limitation of nanoparticle.


2020 ◽  
Vol 17 (6) ◽  
pp. 470-482
Author(s):  
Mori Dhaval ◽  
Jalpa Makwana ◽  
Ekta Sakariya ◽  
Kiran Dudhat

Drug nanocrystals offer an attractive approach for improving the solubility and dissolution rate of poorly soluble drugs which accounts for nearly 40 % newly discovered drug molecules. Both methods for manufacturing drug nanocrystals have high industrial acceptability for being simple and easy to scale which is evident from the number of approved products available in the market. Ability to modify multiple aspects of dosage form like bioavailability, release pattern and dosage form requirement along with flexibility in choosing final dosage form starting from the tablet, capsule, suspension to parenteral one, have made nanocrystal technology one of the very promising and adaptable technology for dosage form design.


2018 ◽  
Vol 6 (2) ◽  
pp. 30-34
Author(s):  
Bayya Subba Rao ◽  
Anuroop Raveendran ◽  
Ratnakar Baki ◽  
Adithya Jinuka

In the current study, a fundamental approach is used to establish operation procedure, for a hand operated double cone blender.  Initially, assuming for a potent drug, where in, the strength of the drug is very less in the final dosage form, a one percent concentration of potassium permanganate with respect to final one kilogram of blended powder using starch as diluent was planned.  With a kind of geometric progression method, at a rate of 10 rotations per minute, the final outcome of the uniform distribution of the potassium permanganate was found to be for at least for fourteen hours of rotations, leading to concentration range of potassium permanganate 0.08 ± 0.025 mg per mg of final blended powder.


Sign in / Sign up

Export Citation Format

Share Document